Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 23 April

Jessica Amir
April 23, 2021

Morning Bell 23 April

Jessica Amir
April 23, 2021

Morning Bell 22 April

Jessica Amir
April 22, 2021

Morning Bell 21 April

Sophia Mavridis
April 21, 2021

Morning Bell 20 April

Sophia Mavridis
April 20, 2021

Morning Bell 19 April

Paulina Peters
April 19, 2021

Weekly Wrap 16 April

Jessica Amir
April 16, 2021

Morning Bell 16 April

Jessica Amir
April 16, 2021

Morning Bell 15 April

Jessica Amir
April 15, 2021

Morning Bell 14 April

Jessica Amir
April 14, 2021

Morning Bell 13 April

Jessica Amir
April 13, 2021